Lupin launches generic Namenda XR capsules in the US

21 Feb 2018 Evaluate

Lupin launches its Memantine Hydrochloride Extended-Release (ER) Capsules, 7mg, 14mg, 21mg, and 28mg having received an approval from the United States Food and Drug Administration (USFDA) earlier.

Memantine Hydrochloride ER capsules are the generic equivalents of Allergan’s Namenda XR capsules. It is used for the treatment of moderate to severe dementia of the Alzheimer’s type. Memantine Hydrochloride had annual sales of approximately Rs 93.60 crore in the US for December 2017.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2176.25 -18.75 (-0.85%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×